Belkyra (Korean and international branding) and Kybella (US branding) — both deoxycholic acid — represent the only FDA-approved injectable specifically designed for submental (under-chin) fat reduction. Korean clinics have integrated this treatment with their refined fat-reduction protocols. This guide explains the mechanism, treatment plan, and realistic outcomes.
What Belkyra/Kybella is
- Synthetic version of deoxycholic acid.
- Naturally occurring molecule that breaks down dietary fat.
- When injected into fatty tissue, destroys fat cells permanently.
- FDA-approved 2015 for submental fat.
- Allergan Korea received marketing approval for Korean market.
How it works
- Deoxycholic acid disrupts fat cell membranes.
- Cell contents released and absorbed by body.
- Fat cells permanently destroyed.
- Macrophages remove debris over weeks.
- Inflammation followed by healing and tissue tightening.
- Permanent fat reduction (cells don\'t regenerate).
Treatment protocol
Standard treatment session
- Multiple small injections under chin.
- 20–50 injection points typical.
- 15–20 minutes per session.
- Topical numbing or ice for comfort.
- Specific injection grid pattern.
Treatment series
- Sessions at least 1 month apart.
- Maximum 6 treatments total.
- Most patients need 2–4 sessions.
- Cumulative effect builds.
- Final result 1–3 months after last treatment.
Korean clinic refinements
- Customized injection pattern based on fat distribution.
- Combined treatments sometimes (lipolysis injections, RF).
- Realistic expectation setting.
- Photographic documentation.
- Conservative dosing initial sessions.
Who is a good candidate
- Mild-to-moderate submental fat.
- Good skin elasticity (skin will redrape).
- Stable weight.
- Healthy adults.
- Realistic expectations.
- Wanting non-surgical option.
Who isn\'t
- Very thin skin elasticity (loose skin won\'t tighten).
- Massive submental fat (better surgical candidate).
- Sagging primarily skin issue.
- Active infection in treatment area.
- Pregnancy or breastfeeding.
- Bleeding disorders.
Common side effects
Expected
- Significant swelling (sometimes alarming) for 3–7 days.
- Bruising 1–2 weeks.
- Pain at injection sites.
- Numbness 4–8 weeks (mostly resolves).
- Areas of hardness for weeks.
- Redness for hours to days.
Rare but serious
- Marginal mandibular nerve injury (temporary asymmetric smile).
- Skin necrosis.
- Permanent neuropathy (very rare).
- Severe allergic reaction.
- Trouble swallowing temporarily.
Recovery considerations
- Plan for visible swelling 5–7 days.
- Avoid major events first 7 days.
- Cold compresses for comfort.
- NSAIDs avoided initially (bleeding).
- Gentle massage as instructed.
- Avoid heavy exercise 48 hours.
- Sleep elevated first nights.
Belkyra/Kybella vs alternatives
vs. Surgical chin liposuction
- Belkyra: less invasive, multiple sessions needed.
- Liposuction: single procedure, surgical recovery, more dramatic results.
- Liposuction often paired with neck lift.
- Choice depends on amount of fat and skin quality.
vs. Lipolysis injections (Lipo-Lab, Kabelline)
- Belkyra: FDA-approved, well-documented.
- Other lipolysis: Korean compounded products.
- Different ingredient profiles.
- Various efficacy levels.
- Belkyra premium pricing reflects approval status.
vs. CoolSculpting
- Belkyra: injection-based, immediate but staged effect.
- CoolSculpting: device-based, gradual effect.
- Different mechanisms (chemical vs. cold).
- Both produce permanent fat reduction.
vs. RF tightening (Profound, FaceTite)
- Belkyra: fat reduction.
- RF: skin tightening primarily.
- Often combined for comprehensive treatment.
- Different goals.
Pricing in Korean clinics 2026
- Per session: ₩400,000–₩900,000.
- USD: $300–$700 per session.
- Series of 4: ₩1,500,000–₩3,500,000.
- USD: $1,150–$2,700 series.
- Premium clinics higher.
- Comparable or lower than U.S. prices.
Realistic outcomes
- Visible reduction in submental fullness.
- Improved chin-neck definition.
- Better profile.
- Subtle skin tightening (modest).
- Permanent results with weight stability.
- Not equivalent to surgical lift for established sagging.
Combined approach with other treatments
- Belkyra + RF for skin tightening.
- Belkyra + Botox jowline lift.
- Belkyra + chin filler for projection.
- Comprehensive lower-face rejuvenation.
- Single surgical session.
Patient experience timeline
Day of treatment
- Numbing 30 minutes.
- Injection 15 minutes.
- Cold compress immediate.
- Mild discomfort.
Day 1–2
- Significant swelling peak.
- "Bullfrog" appearance possible.
- Soft food.
- Cold therapy.
Days 3–7
- Swelling resolving.
- Bruising visible.
- Tenderness present.
- Hard areas developing.
Weeks 2–4
- Swelling mostly gone.
- Bruising fading.
- Some numbness continuing.
- Hard areas softening.
- Subtle reduction visible.
Weeks 4–8 (between sessions)
- Treatment area normalizing.
- Definition improving.
- Ready for next session.
What patients should know
- Significant swelling expected.
- Multiple sessions necessary.
- Permanent fat reduction with weight stability.
- Not equivalent to surgical neck lift.
- Mild skin tightening only.
- Result builds gradually.
For international patients
- Plan trip allowing for swelling resolution.
- Multiple sessions require multiple trips or extended stay.
- Single trip can have 1–2 sessions if spaced 4 weeks.
- Subsequent sessions plan back home if available.
- Korean clinic experienced injection important.
The honest framing
Belkyra/Kybella offers a meaningful non-surgical option for moderate submental fat reduction with permanent results — but multiple sessions are needed, and the swelling phase is significant. The patients who get good outcomes are those whose submental fat is moderate (not massive), whose skin elasticity supports tightening, and who commit to the multi-session protocol with realistic expectations. The patients with substantial fat or significant skin laxity are often better served by surgical neck lift or liposuction. Match the treatment to the anatomy, plan for the multi-session timeline, and accept that subtle gradual improvement is the realistic outcome.